Recent Insights into the Antihypertensive Mechanism of Action of Ketanserin
Present evidence in man is clear and consistent in showing a minor or negligible role of α-1 antagonism in the antihypertensive action of ketanserin. An interaction between marked 5HT-2 and weak α-1 antagonism is by contrast a distinct possibility. The clinical role, if any, of ketanserin in depleting monoamine pools requires to be examined.
KeywordsEssential Hypertension Antihypertensive Action Adrenergic Blockade Antihypertensive Mechanism Biogenic Amine Metabolite
Unable to display preview. Download preview PDF.
- 4.Robertson JIS, Stott DJ, Ball SG. Antihypertensive mode of action of ketanserin. J. of Cardiovasc. Pharmacol. 1987; 10 (Suppl.3): S45–S47.Google Scholar
- 6.Salvati P, Vaghi F, Colombo M, Bianchi G. A new selective antagonist of vascular serotonin receptors lowers blood pressure in spontaneously hypertensive rats. Abstracts, 12th Scientific Meeting of the International Society of Hypertension, Kyoto, 1988, No. 863.Google Scholar
- 9.Donnelly R, Elliott HL, Meredith PA, Reid JL. Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics. Br. J. Clin. Pharmac. 1987; 24, 599–606.Google Scholar
- 13.Robertson JIS, Stott DJ, Ball SG. The serotonin antagonist ketanserin in the treatment of clinical hypertension: a short review. J. of Hypertens. 1986; 4 (Suppl.5): S119–S121.Google Scholar
- 15.Hedner T, Pettersson A, Gradin K, Persson B. Peripheral serotonergic mechanisms in cardiovascular regulation in the spontaneously hypertensive rat. J. of Hypertens. 1986; 4 (Suppl.3): S223–S225.Google Scholar
- 18.Hedner T, Andersson OK, Pettersson A, Persson B. Cardiovascular effects of ketanserin during cold pressure and during isometric and dynamic exercise in hypertensive patients. J. of Cardiovasc. Pharmacol. 1987; 10 (Suppl. 3) 73–77.Google Scholar
- 20.Berdeaux A, Edouard A, Samii K, Guidicelli JF. Ketanserin and the arterial baroreflex in normotensive subjects. Europ. J. Clin. Invest. 1987; 32: 27–34.Google Scholar
- 21.Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PAJ. Identification of nonserotonergic [3H] ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs. J. of Pharmacol. and Experim. Therap. 1988; 244: 310–321.Google Scholar
- 22.Leysen JE, Wynants J, Eens A, Janssen PAJ. Reduction of a particular ketanserin-sensitive monoamine pool in central and peripheral tissues of normotensive and hypertensive rats. Abstracts, International Symposium on Serotonin, Florence, 1989, p. 49.Google Scholar